Two Sigma Advisers’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-151,618
| Closed | -$277K | – | 2529 |
|
|
2024
Q3 | $277K | Buy |
151,618
+71,100
| +88% | +$130K | ﹤0.01% | 1940 |
|
|
2024
Q2 | $167K | Buy |
80,518
+53,500
| +198% | +$111K | ﹤0.01% | 2248 |
|
|
2024
Q1 | $108K | Hold |
27,018
| – | – | ﹤0.01% | 2300 |
|
|
2023
Q4 | $50.7K | Sell |
27,018
-800
| -3% | -$1.5K | ﹤0.01% | 2396 |
|
|
2023
Q3 | $46.5K | Sell |
27,818
-3,500
| -11% | -$5.85K | ﹤0.01% | 2281 |
|
|
2023
Q2 | $74.9K | Sell |
31,318
-300
| -0.9% | -$717 | ﹤0.01% | 2239 |
|
|
2023
Q1 | $99K | Sell |
31,618
-15,600
| -33% | -$48.8K | ﹤0.01% | 2386 |
|
|
2022
Q4 | $127K | Sell |
47,218
-5,200
| -10% | -$13.9K | ﹤0.01% | 2267 |
|
|
2022
Q3 | $155K | Sell |
52,418
-700
| -1% | -$2.07K | ﹤0.01% | 2251 |
|
|
2022
Q2 | $156K | Sell |
53,118
-12,800
| -19% | -$37.6K | ﹤0.01% | 2323 |
|
|
2022
Q1 | $337K | Sell |
65,918
-105,000
| -61% | -$537K | ﹤0.01% | 2171 |
|
|
2021
Q4 | $1.15M | Buy |
170,918
+2,100
| +1% | +$14.2K | ﹤0.01% | 1487 |
|
|
2021
Q3 | $1.17M | Buy |
168,818
+110,500
| +189% | +$765K | ﹤0.01% | 1544 |
|
|
2021
Q2 | $568K | Buy |
58,318
+46,200
| +381% | +$450K | ﹤0.01% | 1892 |
|
|
2021
Q1 | $191K | Sell |
12,118
-7,400
| -38% | -$117K | ﹤0.01% | 2360 |
|
|
2020
Q4 | $473K | Buy |
+19,518
| New | +$473K | ﹤0.01% | 1883 |
|